Colorectal cancer (CRC) accounts for about 10% of all new cancer cases globally. Located
at close proximity to the colorectal epithelium, the gut microbiota comprises a large …

Recently, relationship between gut microbiota composition and development of obesity has
been pointed. However, the gut microbiota composition of individual with obesity is not …

Low-grade inflammation is the hallmark of metabolic disorders such as obesity, type 2
diabetes and nonalcoholic fatty liver disease. Emerging evidence indicates that these …

Researchers have discovered associations between elements of the intestinal microbiome
(including specific microbes, signaling pathways, and microbiota-related metabolites) and …

The global obesity epidemic has necessitated the search for better intervention strategies
including the exploitation of the health benefits of some gut microbiota and their metabolic …

Gut microbiome has been identified in the past decade as an important factor involved in
obesity, but the magnitude of its contribution to obesity and its related comorbidities is still …

Stress, a ubiquitous part of daily human life, has varied biological effects which are
increasingly recognized as including modulation of commensal microorganisms residing in …

Targeting gut microbiota with synbiotics (probiotic supplements containing prebiotic
components) is emerging as a promising intervention in the comprehensive nutritional …

Aims/hypothesis The aim was to conduct a systematic review and meta-analysis of
randomised controlled clinical trials assessing the effect of probiotic, prebiotic or synbiotic …

To summarize the microbiome's role in metabolic disorders (insulin resistance,
hyperglycemia, type 2 diabetes, obesity, hyperlipidemia, hypertension, nonalcoholic fatty …